Canna~Fangled Abstracts

Medical Cannabis as an Effective Treatment for Refractory Symptoms of Paraneoplastic Stiff Person Syndrome

By November 20, 2019 No Comments

Diane Portman, MD'Correspondence information about the author MD Diane PortmanKristine A. Donovan, PhD, Margarita Bobonis, MD Department of Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida, USA

Stiff person syndrome (SPS) is a disorder characterized by fluctuating, progressive and painful spasms of the limbs, trunk and face. The condition is frequently associated with other diseases, including malignancies1. Up to 10% of SPS cases are paraneoplastic (PSPS) and occur with various types of cancer 2. SPS is thought to be immune-mediated, with up to 60% of patients demonstrating antibodies to glutamic acid decarboxylase (GAD), the rate-limiting enzyme for the production of the inhibitory neurotransmitter γ-aminobutyric acid (GABA).

To access this article, please choose from the options below

Purchase access to this article

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

Key Message: This article describes a case of paraneoplastic stiff person syndrome and a novel treatment paradigm including medical cannabis. The outcomes suggest that state medical marijuana program-sanctioned THC/CBD products may provide relief for patients with refractory symptoms in this autoimmune neurologic condition. Further study is indicated.

Leave a Reply

en English